0001415889-23-014916.txt : 20231108 0001415889-23-014916.hdr.sgml : 20231108 20231108175547 ACCESSION NUMBER: 0001415889-23-014916 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231106 FILED AS OF DATE: 20231108 DATE AS OF CHANGE: 20231108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lentini Renee CENTRAL INDEX KEY: 0001838777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 231389448 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoGen, Inc. CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGEN INC DATE OF NAME CHANGE: 19920703 4 1 form4-11082023_101139.xml X0508 4 2023-11-06 0000855654 ImmunoGen, Inc. IMGN 0001838777 Lentini Renee C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451 false true false false VP & PRIN ACCTG OFFICER 0 Common Stock 2023-11-06 4 M 0 9000 10.79 A 108017 D Common Stock 2023-11-06 4 M 0 2619 2.68 A 110636 D Common Stock 2023-11-06 4 M 0 23000 10.65 A 133636 D Common Stock 2023-11-06 4 M 0 14373 5.25 A 148009 D Common Stock 2023-11-06 4 M 0 4024 6.98 A 152033 D Common Stock 2023-11-06 4 M 0 55550 7.69 A 207583 D Common Stock 2023-11-06 4 M 0 11962 5.32 A 219545 D Common Stock 2023-11-06 4 S 0 219545 15.29 D 0 D Stock Option (right to buy) 10.79 2023-11-06 4 M 0 9000 0 D 2024-07-17 Common Stock 9000 0 D Stock Option (right to buy) 2.68 2023-11-06 4 M 0 2619 0 D 2026-09-30 Common Stock 2619 0 D Stock Option (right to buy) 10.65 2023-11-06 4 M 0 23000 0 D 2028-02-15 Common Stock 23000 0 D Stock Option (right to buy) 5.25 2023-11-06 4 M 0 14373 0 D 2029-01-31 Common Stock 14373 0 D Stock Option (right to buy) 6.98 2023-11-06 4 M 0 4024 0 D 2031-01-08 Common Stock 4024 12625 D Stock Option (right to buy) 7.69 2023-11-06 4 M 0 55550 0 D 2031-02-05 Common Stock 55550 25250 D Stock Option (right to buy) 5.32 2023-11-06 4 M 0 11962 0 D 2032-02-04 Common Stock 11962 53831 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges. This option was granted on 7/17/2014 and is fully vested as of the transaction date. This option was granted on 9/30/2016 and is fully vested as of the transaction date. This option was granted on 2/15/2018 and is fully vested as of the transaction date. This option was granted on 1/31/2019 and is fully vested as of the transaction date. This option was granted on 1/8/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years. This option was granted on 2/5/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years. This option was granted on 2/4/2022 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years. /s/ Renee Lentini 2023-11-08